Breast cancer specialist to receive lecture award
Jeffrey M. Rosen, PhD, will receive the William L. McGuire Memorial Lecture Award at this year’s San Antonio Breast Cancer Symposium, scheduled for December 6-10.
The award will recognize Rosen for her contributions to preclinical and translational breast cancer research, as well as her commitment to transdisciplinary collaboration and mentorship of early career scientists.
“I am honored to receive the McGuire Award,” Rosen said in a press release. “I first met Bill McGuire over 50 years ago at a Hormone Action Gordon research conference, and was fortunate to have many scientific interactions with him during his lifetime. .
“Bill inspired and encouraged my career in breast cancer research,” Rosen added. “I hope that the development and use of preclinical models of breast cancer will be important in personalizing and modifying treatment options, especially in terms of combining therapies and the use of immunotherapy in cancer treatment. metastatic breast.”
Jeffrey M. Rosen
Rosen is Distinguished Professor of Molecular and Cellular Biology and Co-Lead of the Breast Cancer Program at the Dan L Duncan Comprehensive Cancer Center at Baylor College of Medicine.
He has made several key contributions to the fields of mammary gland biology and endocrinology. He participated in the first studies that elucidated the mechanisms of action of interferon, which contributed to the discovery of the JAK/STAT pathway.
He has also mentored over 100 graduate students, postdoctoral fellows, and junior faculty members.
Rosen will present a talk at SABCS titled “Leveraging Preclinical Models for Translational Breast Cancer Research”.
“Dr. Rosen’s contributions to breast cancer discovery and translational research have been an example to many of us in this field. He is an outstanding recipient of the McGuire Award,” Carlos L. Arteaga, MD, FAACR, director of Simmons Comprehensive Cancer Center, associate dean of oncology at UT Southwestern Medical Center and co-director of SABCS, said in the statement.